InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Kelly Michael Aaron, Director. Insider active across 4 companies, notably DMC Global Inc.. Cumulatively, 13 filings have been recorded. The latest transaction was disclosed on 13 May 2026 — Attribution. Regulator: SEC (Form 4). The full history is free.
Declarations13 total
016,937 shares0
Common Stock
SEC:0001769668-26-000002·
016,937 shares0
Common Stock
SEC:0001769668-26-000002:0·
015,556 shares0
Common Stock
SEC:0001077183-22-000113:0·
012,671 shares0
Common Stock
SEC:0001209191-22-035831:0·
05,006 shares0
Common Stock
SEC:0000034067-22-000076:0·
04,610 shares0
Common Stock
SEC:0001567619-21-012874·
04,610 shares0
Common Stock
SEC:0001567619-21-012874:0·
010,115 shares0
Common Stock
SEC:0001209191-21-040387·
010,115 shares0
Common Stock
SEC:0001209191-21-040387:0·
03,081 shares0
Common Stock
SEC:0001077183-21-000161·
03,081 shares0
Common Stock
SEC:0001077183-21-000161:0·
01,888 shares0
Common Stock
SEC:0000034067-21-000077·
01,888 shares0
Common Stock
SEC:0000034067-21-000077:0·
13 of 13 declarations
About Kelly Michael Aaron
Michael Aaron Kelly is a Director at DMC Global Inc., Neogenomics Inc., and Amicus Therapeutics, Inc. In this role, he participates in strategic decision-making and the direction of operations for these companies. Kelly brings his expertise to guide growth and innovation initiatives, thereby contributing to the success of each organization.
